WEBULL
WebtradeDownload

Is Loblaw Companies (TSX:L) Fairly Valued After Renewed Confidence In Its Grocery And Pharmacy Business?

Simply Wall St · 1d ago

Why Loblaw Companies Stock Is Back On Investors’ Radar

Loblaw Companies (TSX:L) has caught attention after a modest share price move linked to steady interest in its grocery and pharmacy operations, as investors gravitate toward essential goods providers during broader market uncertainty.

Recent trading tells you investors are still engaged. The latest close at CA$62.68 comes with a marginally positive year to date share price return, while a 1 year total shareholder return of 14.5% and a 5 year total shareholder return of 191.88% point to a stock that has rewarded patience even as near term share price momentum has cooled.

Short bursts of buying after news about Loblaw Companies’ defensive grocery and pharmacy exposure and fresh product initiatives, such as the updated PC Nutrition First pet food range, suggest changing perceptions of risk and reliability rather than a reaction to the Weston family’s separate Boots deal, which does not affect Loblaw’s financials.

Spot defensive retail momentum like Loblaw Companies and then pressure test your watchlist against our curated 8 resilient stocks with low risk scores, which focuses on resilience when markets turn choppy.

So is this latest move in Loblaw Companies a clear indication of a dependable CA$65.1b grocery and pharmacy operation, or is it primarily a shift in sentiment that the valuation now needs to test?

Most Popular Narrative: 9% Undervalued

The most followed valuation storyline puts Loblaw Companies’ fair value at CA$68.80, above the recent CA$62.68 close. This frames the latest share price drift as a modest discount rather than a stretch.

Loblaw's integrated expansion of in-store pharmacy clinics and enhanced primary care services is capitalizing on rising healthcare needs and an aging population, driving higher pharmacy traffic, prescription volumes, and cross-selling opportunities, positively impacting same-store sales and net margins.

See why 48 investors see Loblaw Companies as 9% undervalued.

Result: Fair Value of CA$68.80 (UNDERVALUED)

Still, the Loblaw Companies story relies on execution, with tougher online competition and potential regulatory pressure on food pricing both capable of upsetting that fair value narrative.

Find out about the key risks to this Loblaw Companies narrative.

Another Take On Loblaw Companies’ Valuation

The fair value story around Loblaw Companies looks tidy at CA$68.80, yet the SWS DCF model points in a different direction. On that cash flow view, the stock at CA$62.68 trades above an estimated value of CA$49.91, which screens as overvalued. Which lens feels more useful for your own checklist?

For a closer look at how this cash flow view is built and what would need to change for the gap to close, walk through the Look into how the SWS DCF model arrives at its fair value..

L Discounted Cash Flow as at Oct 2026
L Discounted Cash Flow as at Oct 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Loblaw Companies for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 7 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mixed mood around Loblaw Companies has you on the fence, treat that tension as a cue to interrogate the numbers yourself and move fast to shape your own view. You can start with the 2 key rewards and 2 important warning signs.

Looking For More Ideas Beyond Loblaw Companies?

If Loblaw Companies has sharpened your focus, do not stop here. The real edge comes from lining it up against other high quality ideas discovered systematically.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.